You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 13, 2024

Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)

Docket ⤷  Try a Trial Date Filed 2018-12-11
Court District Court, D. Delaware Date Terminated 2021-05-17
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties BIONPHARMA INC.
Patents 10,039,745; 10,154,987; 10,183,004; 10,232,003; 10,279,012; 10,279,014; 6,168,016; 6,211,244; 6,316,460; 8,183,002; 8,222,015; 8,568,747; 9,194,011; 9,242,011; 9,297,019; 9,375,405; 9,669,008; 9,808,442
Attorneys Kristina A. Hanson
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .

Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-12-13 and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-07-22 136 Notice of Service Byrn on Infringement of U.S. Patent Nos. 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-10-19 145 Notice of Service Stephen Byrn on the Infringement of U.S. Patents 10,039,745 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-10-30 147 Attachment 2 accord D.I. 353 at 182:10-183:4). C. Prosecution of the ’405 Patent 1. …two new patents. Amneal and Bionpharma were coordinated as to the first four Epaned patents for good… first set of Epaned patents to issue (the ’008, ’442, ’745, and ’987 patents). (C.A. No. 19-678 against…involves two patents that did not issue until September 2020 (the ’868 and ’482 patents), but that are…asserts the same six patents against both Amneal and Bionpharma. All six patents deal with the same technology External link to document
2020-12-09 166 Stipulation of Dismissal and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-10-31 22 Proposed Order 19-1067, which relates to asserted U.S. Patent No. 10,154,987, should also be included herein with the…and Judge Stark’s Revised Procedures for Managing Patent Cases (which is posted at 1 The parties…www.ded.uscourts.gov; see Chambers, Judge Leonard P. Stark, Patent Cases), and the parties having determined after…Identification of Accused Product(s) and Asserted Patent(s). By December… and the asserted patent(s) they alleged infringe, and produce the External link to document
2021-04-22 251 200:7, 190:10, 190:24, 231:10, 232:3, INC [3] - 163:3, 163:6, 276:19 …288:15 studied [1] - 248:15 231:10, 232:3, sorbate [1] - 304:24 squares [1…across four patents: the '008, '442, '745, and '987 9 patents. 10… Two patents essentially cover the oral liquid 11 formulation, two other patents cover methods…across two patents asserted 21 against Bionpharma: The '745 and '987 patent. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.